Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure.
Teive
Hélio A G
HA
Munhoz
Renato P
RP
Werneck
Lineu C
LC
D000368:Aged; D006177:Gynecomastia / Q000139:chemically induced*; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects*; D009069:Movement Disorders / Q000209:etiology*; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy; D013148:Spironolactone / Q000009:adverse effects*
D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone